Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
Provided By GlobeNewswire
Last update: May 6, 2025
GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 13, 2025.
Read more at globenewswire.com
